 |
Peter R. Carroll, MD
Recent Publications |
Publications – 2008 |
 |
Agarwal, P.K., N. Sadetsky, B.R.
Konety, M.I. Resnick, and P.R. Carroll, Treatment failure
after primary and salvage therapy for prostate cancer: likelihood,
patterns of care, and outcomes. Cancer, 2008. 112(2): p.
307-14. |
|
Choueiri, T.K., R. Dreicer, A. Paciorek,
P.R. Carroll, and B. Konety, A model that predicts the probability
of positive imaging in prostate cancer cases with biochemical
failure after initial definitive local therapy. J Urol, 2008.
179(3): p. 906-10; discussion 910. |
|
Chung, C.S., M.H. Chen, J. Cullen, D.
McLeod, P. Carroll, and A.V. D'Amico, Time to prostate-specific
antigen nadir after androgen suppression therapy for postoperative
or postradiation PSA failure and risk of prostate cancer-specific
mortality. Urology, 2008. 71(1): p. 136-40. |
|
Dall'era, M.A., M.R. Cooperberg, J.M.
Chan, B.J. Davies, P.C. Albertsen, L.H. Klotz, C.A. Warlick,
L. Holmberg, D.E. Bailey, Jr., M.E. Wallace, P.W. Kantoff,
and P.R. Carroll, Active surveillance for early-stage prostate
cancer: review of the current literature. Cancer, 2008. |
|
Davies, B.J., T.J. Walsh, P.L. Ross,
S.J. Knight, N. Sadetsky, P.R. Carroll, and C.J. Kane, Effect
of BMI on Primary Treatment of Prostate Cancer. Urology,
2008. |
|
Kurhanewicz, J., D. Vigneron, P. Carroll,
and F. Coakley, Multiparametric magnetic resonance imaging
in prostate cancer: present and future. Curr Opin Urol, 2008.
18(1): p. 71-7. |
|
Lee, I.H., N. Sadetsky, P.R. Carroll,
and H.M. Sandler, The impact of treatment choice for localized
prostate cancer on response to phosphodiesterase inhibitors.
J Urol, 2008. 179(3): p. 1072-6; discussion 1076. |
|
Sadetsky, N., D.P. Lubeck, D.J. Pasta,
D.M. Latini, J. DuChane, and P.R. Carroll, Insurance and
quality of life in men with prostate cancer: data from the
Cancer of the Prostate Strategic Urological Research Endeavor.
BJU Int, 2008. 101(6): p. 691-7. |
|
Shah, J.B., J.M. McKiernan, E.P. Elkin,
P.R.
Carroll, and M.V. Meng, Prostate biopsy patterns in
the CaPSURE database: evolution with time and impact on outcome
after prostatectomy. J Urol, 2008. 179(1): p. 136-40. |
|
Westphalen, A.C., F.V. Coakley, A.
Qayyum, M. Swanson, J.P. Simko, Y. Lu, S. Zhao, P.R.
Carroll,
B.M. Yeh, and J. Kurhanewicz, Peripheral zone prostate cancer:
accuracy of different interpretative approaches with MR and
MR spectroscopic imaging. Radiology, 2008. 246(1): p. 177-84. |
| |
Publications – 2007 |
|
Alexander, B.M., M.H. Chen, P. Carroll,
and A.V. D'Amico, Prostate-specific antigen level at initiation
of hormonal therapy after prostate-specific antigen failure
following prostatectomy or radiotherapy and therapeutic response.
Urology, 2007. 70(2): p. 320-3. |
|
Arredondo, S.A., D.M. Latini, N. Sadetsky,
J. Kawakami, D.J. Pasta, J. DuChane, and P.R.
Carroll, Quality
of life for men receiving a second treatment for prostate
cancer. J Urol, 2007. 177(1): p. 273-8; discussion 278-9. |
|
Berglund, R.K., N. Sadetsky, J. DuChane,
P.R. Carroll, and E.A. Klein, Limited pelvic lymph node dissection
at the time of radical prostatectomy does not affect 5-year
failure rates for low, intermediate and high risk prostate
cancer: results from CaPSURE. J Urol, 2007. 177(2): p. 526-29;
discussion 529-30. |
|
Boorjian, S., J.E. Cowan, B.R. Konety,
J. DuChane, A. Tewari, P.R. Carroll, and C.J. Kane, Bladder
cancer incidence and risk factors in men with prostate cancer:
results from Cancer of the Prostate Strategic Urologic Research
Endeavor. J Urol, 2007. 177(3): p. 883-7; discussion 887-8. |
|
Coakley, F.V., I. Chen, A. Qayyum, A.C.
Westphalen, P.R. Carroll, H. Hricak, M.H. Chen, and J. Kurhanewicz,
Validity of prostate-specific antigen as a tumour marker
in men with prostate cancer managed by watchful-waiting:
correlation with findings at serial endorectal magnetic resonance
imaging and spectroscopic imaging. BJU Int, 2007. 99(1):
p. 41-5. |
|
Cooperberg, M.R., J.M. Broering, P.W. Kantoff,
and P.R. Carroll, Contemporary trends in low risk prostate cancer: risk assessment
and treatment. J Urol, 2007. 178(3
Pt 2): p. S14-9. |
|
D'Amico, A.V., D.G. McLeod, P.R.
Carroll,
J. Cullen, and M.H. Chen, Time to an undetectable prostate-specific
antigen (PSA) after androgen suppression therapy for postoperative
or postradiation PSA recurrence and prostate cancer-specific
mortality. Cancer, 2007. 109(7): p. 1290-5. |
|
Dall'Era, M. and P.R.
Carroll, Prostate
cancer--more information and more questions. J Urol, 2007.
177(5): p. 1607-8. |
|
David, K.A., M.I. Milowsky, J. Ritchey,
P.R. Carroll, and D.M. Nanus, Low incidence of perioperative
chemotherapy for stage III bladder cancer 1998 to 2003: a
report from the National Cancer Data Base. J Urol, 2007.
178(2): p. 451-4. |
|
Dewell, A., G. Weidner, M.D. Sumner, R.J.
Barnard, R.O. Marlin, J.J. Daubenmier, C. Chi, P.R. Carroll,
and D. Ornish, Relationship of dietary protein and soy isoflavones
to serum IGF-1 and IGF binding proteins in the Prostate Cancer
Lifestyle Trial. Nutr Cancer, 2007. 58(1): p. 35-42. |
|
Eggener, S.E., P.T. Scardino, P.R. Carroll,
M.J. Zelefsky, O. Sartor, H. Hricak, T.M. Wheeler, S.W. Fine,
J. Trachtenberg, M.A. Rubin, M. Ohori, K. Kuroiwa, M. Rossignol,
and L. Abenhaim, Focal therapy for localized prostate cancer:
a critical appraisal of rationale and modalities. J Urol,
2007. 178(6): p. 2260-7. |
|
Elliott, S.P., M.V. Meng, E.P. Elkin, J.W.
McAninch, J. Duchane, and P.R. Carroll, Incidence of urethral
stricture after primary treatment for prostate cancer: data
From CaPSURE. J Urol, 2007. 178(2): p. 529-34; discussion
534. |
|
Hom, J.J., F.V. Coakley, J.P. Simko, Y.
Lu, A. Qayyum, A.C. Westphalen, L.D. Schmitt, P.R.
Carroll,
and J. Kurhanewicz, High-grade prostatic intraepithelial
neoplasia in patients with prostate cancer: MR and MR spectroscopic
imaging features--initial experience. Radiology, 2007. 242(2):
p. 483-9. |
|
Kantoff, P.W., T.M. Beer, A.V. D'Amico, R.S. Dipaola,
M.A. Eisenberger, M.H. Hussain, W.K. Kelly, P. Mathew, M.J.
Morris, C.J. Ryan, H.M. Sandler, I.M. Thompson, and P.R. Carroll, Innovations
and challenges in prostate cancer: summary statement for
the 6th Cambridge Conference. J Urol, 2007. 178(3 Pt 2): p. S5-8; quiz
S4. |
|
Kawachi, M.H., R.R. Bahnson, M. Barry, P.R. Carroll,
H.B. Carter, W.J. Catalona, J.I. Epstein, R.B. Etzioni, G.P. Hemstreet,
3rd, R.J. Howe, J.D. Kopin, P.H. Lange, H. Lilja, J. Mohler, J. Moul,
R.B. Nadler, S. Patterson, A. Pollack, J.C. Presti, A.M. Stroup, D.A.
Urban, R. Wake, and J.T. Wei, Prostate cancer early detection. Clinical
practice guidelines in oncology. J Natl Compr Canc Netw, 2007. 5(7):
p. 714-36. |
|
Knight, S.J., D.M. Latini, S.L. Hart, N.
Sadetsky, C.J. Kane, J. DuChane, and P.R.
Carroll, Education
predicts quality of life among men with prostate cancer cared
for in the Department of Veterans Affairs: a longitudinal
quality of life analysis from CaPSURE. Cancer, 2007. 109(9):
p. 1769-76. |
|
Konety, B.R., V. Allareddy, and P.R.
Carroll,
Factors affecting outcomes after radical cystectomy in African
Americans. Cancer, 2007. 109(3): p. 542-8. |
|
Konety, B.R., N. Sadetsky, and P.R.
Carroll,
Recovery of urinary continence following radical prostatectomy:
the impact of prostate volume--analysis of data from the
CaPSURE Database. J Urol, 2007. 177(4): p. 1423-5; discussion
1425-6. |
|
Latini, D.M., S.L. Hart, S.J. Knight, J.E. Cowan,
P.L. Ross, J. Duchane, and P.R. Carroll, The relationship between anxiety
and time to treatment for patients with prostate cancer on surveillance.
J Urol, 2007. 178(3 Pt 1): p. 826-31; discussion 831-2. |
|
Lee, W.R., J. Sharkey, J.E. Cowan, J. DuChane,
and P.R. Carroll, Prostate brachytherapy: a descriptive analysis
from CaPSURE. Brachytherapy, 2007. 6(2): p. 123-8. |
|
Macdonald, O.K., A.V. D'Amico, N. Sadetsky, D.C. Shrieve, and P.R.
Carroll,
Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen
recurrence from the CaPSURE database. Urology, 2007. 70(1): p. 106-10. |
|
Ryan, C.J., E.P. Elkin, J. Cowan, and
P.R. Carroll, Initial treatment patterns and outcome of contemporary
prostate cancer patients with bone metastases at initial
presentation: data from CaPSURE. Cancer, 2007. 110(1): p.
81-6. |
|
Sadetsky, N., E.P. Elkin, D.M. Latini, J. Duchane,
and P.R.
Carroll, Prostate cancer outcomes among older men: insurance
status comparisons results from CaPSURE database. Prostate Cancer Prostatic
Dis, 2007. |
|
Scales, C.D., Jr., J.W. Moul, L.H. Curtis, E.P. Elkin, M.E. Hughes, and P.R.
Carroll, Prostate cancer in the Baby Boomer generation: results from CaPSURE.
Urology, 2007. 70(6): p. 1162-7. |
|
Tsai, H.K., A.V. D'Amico, N. Sadetsky, M.H. Chen, and P.R.
Carroll, Androgen
deprivation therapy for localized prostate cancer and the risk of cardiovascular
mortality. J Natl Cancer Inst, 2007. 99(20): p. 1516-24. |
|
Walsh, T.J., M.A. Dall'Era, M.S. Croughan, P.R.
Carroll, and P.J. Turek,
Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of
testicular cancer. J Urol, 2007. 178(4 Pt 1): p. 1440-6; discussion 1446. |
|
Wilson, L.S., R. Tesoro, E.P. Elkin, N.
Sadetsky, J.M. Broering, D.M. Latini, J. DuChane, R.R. Mody,
and P.R. Carroll, Cumulative cost pattern comparison of prostate
cancer treatments. Cancer, 2007. 109(3): p. 518-27. |
|
Wright, J.L., D.W. Lin, J.E. Cowan, P.R.
Carroll, and M.S. Litwin, Quality of life in young men after
radical prostatectomy. Prostate Cancer Prostatic Dis, 2007. |
| |
|
| |
Publications – 2006 |
|
Arredondo, S.A., E.P. Elkin, P.L. Marr,
D.M. Latini, J. DuChane, M.S. Litwin, and P.R.
Carroll, Impact
of comorbidity on health-related quality of life in men undergoing
radical prostatectomy: data from CaPSURE. Urology, 2006.
67(3): p. 559-65. |
|
Carroll, P.R., Modifying urology residency
training: time to speed up or slow down? J Urol, 2006. 175(3
Pt 1): p. 811-2. |
|
Carroll, P.R., F.V. Coakley, and J. Kurhanewicz,
Magnetic resonance imaging and spectroscopy of prostate cancer.
Rev Urol, 2006. 8 Suppl 1: p. S4-S10. |
|
Cooperberg, M.R., S.J. Freedland, D.J.
Pasta, E.P. Elkin, J.C. Presti, Jr., C.L. Amling, M.K. Terris,
W.J. Aronson, C.J. Kane, and P.R. Carroll, Multiinstitutional
validation of the UCSF cancer of the prostate risk assessment
for prediction of recurrence after radical prostatectomy.
Cancer, 2006. 107(10): p. 2384-91. |
|
Daubenmier, J.J., G. Weidner, R. Marlin,
L. Crutchfield, S. Dunn-Emke, C. Chi, B. Gao, P.
Carroll,
and D. Ornish, Lifestyle and health-related quality of life
of men with prostate cancer managed with active surveillance.
Urology, 2006. 67(1): p. 125-30. |
|
Efstathiou, J.A., M.H. Chen, W.J. Catalona,
D.G. McLeod, P.R. Carroll, J.W. Moul, K.A. Roehl, and A.V.
D'Amico, Prostate-specific antigen-based serial screening
may decrease prostate cancer-specific mortality. Urology,
2006. 68(2): p. 342-7. |
|
Eisenberg, M.S., M.V. Meng, V.A. Master,
M.L. Stoller, B.I. Rini, P.R. Carroll, and C.J. Kane, Laparoscopic
versus open cytoreductive nephrectomy in advanced renal-cell
carcinoma. J Endourol, 2006. 20(7): p. 504-8. |
|
Enokida, H., H. Shiina, S. Urakami, M.
Terashima, T. Ogishima, L.C. Li, M. Kawahara, M. Nakagawa,
C.J. Kane, P.R. Carroll, M. Igawa, and R. Dahiya, Smoking
influences aberrant CpG hypermethylation of multiple genes
in human prostate carcinoma. Cancer, 2006. 106(1): p. 79-86. |
|
Greene, K.L., E.P. Elkin, A. Karapetian,
J. Duchane, P.R. Carroll, and C.J. Kane, Prostate biopsy
tumor extent but not location predicts recurrence after radical
prostatectomy: results from CaPSURE. J Urol, 2006. 175(1):
p. 125-9; discussion 129. |
|
Hom, J.J., F.V. Coakley, J.P. Simko, A.
Qayyum, Y. Lu, L. Schmitt, P.R. Carroll, and J. Kurhanewicz,
Prostate cancer: endorectal MR imaging and MR spectroscopic
imaging--distinction of true-positive results from chance-detected
lesions. Radiology, 2006. 238(1): p. 192-9. |
|
Kawakami, J., J.E. Cowan, E.P. Elkin, D.M.
Latini, J. DuChane, and P.R. Carroll, Androgen-deprivation
therapy as primary treatment for localized prostate cancer:
data from Cancer of the Prostate Strategic Urologic Research
Endeavor (CaPSURE). Cancer, 2006. 106(8): p. 1708-14. |
|
Kawakami, J., M.V. Meng, N. Sadetsky, D.M.
Latini, J. Duchane, and P.R. Carroll, Changing patterns of
pelvic lymphadenectomy for prostate cancer: results from
CaPSURE. J Urol, 2006. 176(4 Pt 1): p. 1382-6. |
|
Latini, D.M., J.M. Chan, J.E. Cowan, S.A.
Arredondo, C.J. Kane, D.F. Penson, J. DuChane, and P.R.
Carroll,
Health-related quality of life for men with prostate cancer
and diabetes: a longitudinal analysis from CaPSURE. Urology,
2006. 68(6): p. 1242-7. |
|
Latini, D.M., E.P. Elkin, M.R. Cooperberg,
N. Sadetsky, J. Duchane, and P.R. Carroll, Differences in
clinical characteristics and disease-free survival for Latino,
African American, and non-Latino white men with localized
prostate cancer: data from CaPSURE. Cancer, 2006. 106(4):
p. 789-95. |
|
Marr, P.L., E.P. Elkin, S.A. Arredondo,
J.M. Broering, J. DuChane, and P.R.
Carroll, Comorbidity
and primary treatment for localized prostate cancer: data
from CaPSURE. J Urol, 2006. 175(4): p. 1326-31. |
|
Meng, M.V., E.P. Elkin, J. DuChane, and
P.R. Carroll, Impact of increased number of biopsies on the
nature of prostate cancer identified. J Urol, 2006. 176(1):
p. 63-8; discussion 69. |
|
Paris, P.L., M.D. Hofer, G. Albo, R. Kuefer,
J.E. Gschwend, R.E. Hautmann, J. Fridyland, J. Simko, P.R.
Carroll, M.A. Rubin, and C. Collins, Genomic profiling of
hormone-naive lymph node metastases in patients with prostate
cancer. Neoplasia, 2006. 8(12): p. 1083-9. |
|
Ryan, C.J., E.P. Elkin, E.J. Small, J.
Duchane, and P. Carroll, Reduced incidence of bony metastasis
at initial prostate cancer diagnosis: data from CaPSURE.
Urol Oncol, 2006. 24(5): p. 396-402. |
|
Swanson, M.G., A.S. Zektzer, Z.L. Tabatabai,
J. Simko, S. Jarso, K.R. Keshari, L. Schmitt, P.R.
Carroll,
K. Shinohara, D.B. Vigneron, and J. Kurhanewicz, Quantitative
analysis of prostate metabolites using (1)H HR-MAS spectroscopy.
Magn Reson Med, 2006. 55(6): p. 1257-64. |
|
Thompson, I.M., P.R.
Carroll, and M.A.
Carducci, Recommendations for defining and treating high
risk localized prostate cancer. J Urol, 2006. 176(6 Pt 2):
p. S6-S10; quiz S3-5. |
|
Tsai, H.K., M.H. Chen, D.G. McLeod, P.R.
Carroll, J.P. Richie, and A.V. D'Amico, Cancer-specific mortality
after radiation therapy with short-course hormonal therapy
or radical prostatectomy in men with localized, intermediate-risk
to high-risk prostate cancer. Cancer, 2006. 107(11): p. 2597-603. |
| |
| |
return
to top
|
|
|
|
|
|
